NGeneBio attended the Korean Society of Diagnostic Hematology Fall Workshop, which took place on September 7, 2023.

During this event, NGeneBio focused on showcasing HEMEaccuTest™, an innovative product that enables precision diagnosis and prognosis prediction for a wide range of blood cancers, including myelodysplastic syndromes, myeloproliferative neoplasms, lymphoma, and acute myeloid leukemia. Additionally, NGeneBio introduced various precision cancer diagnostic products based on their NGS technology.

NGeneBio is committed to providing innovative products and expanding the market through active collaboration and information exchange with healthcare professionals and the industry, both domestically and internationally.